Tag: Prescription Drugs
Access to High-Cost Targeted Treatments Varies for Lung Cancer
Patients treated at a National Cancer Institute-designated center more likely to receive these drugs for lung cancer
Facebook Asked to Remove ‘Factually Inaccurate’ Ads About PrEP
Ads are from law firms seeking litigants for class-action lawsuit against Truvada maker Gilead Sciences
Potentially Nephrotoxic Meds Prescribed to Children With CKD
Potentially nephrotoxic meds prescribed at higher rate to children with versus without chronic kidney disease
Cost Saving-Related Rx Nonadherence Found for 7 Percent With HIV
Persons nonadherent due to cost more likely to have visited ED, been hospitalized, not be virally suppressed
Use of Pain, Sleep Drugs Ups Risk for Frailty in the Elderly
Findings show 95 percent increased frailty risk for co-use of sleep, pain drugs
Factors Examined for Time to First Rx for Biologic DMARD in RA
Longer time to receipt more likely with older age, male sex, greater distance to nearest rheumatologist
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
Many With Diabetes Engage in Underground Exchange of Medications, Supplies
Diabetes-specific financial stress predicts engagement in trading, receiving donated meds, supplies
Pharmacist-Led Interventions Cut Cardiovascular Risk Factors
Interventions associated with drops in blood pressure, cholesterol, HbA1c
